Toxicological Assessment of D-Allulose from a Novel One-Step Fermentation Process Using Genetic Methods

A direct answer for your safety file

You need a clean toxicology study for allulose. This one delivers. Researchers ran a 90-day oral toxicity study in rats with D-allulose produced by a one-step fermentation process using a genetically engineered E. coli AS10 strain. The no-observed-adverse-effect level, or NOAEL, came out at 8000 mg/kg body weight per day. That gives formulators and buyers a solid number to work with. The paper carries DOI: 10.1155/jt/6597561.

Why this paper exists

Allulose has attracted serious attention as a sugar replacement. It gives you solubility, texture, and thermal stability similar to sucrose. But the production process matters. A one-step fermentation route using E. coli AS10 is not the same as every other manufacturing method. So the study asks a specific question: is the ingredient safe when you produce it this way? The safety data answers that with a 90-day rat model.

What the study did

The research team ran a 90-day oral toxicity study. They evaluated D-allulose made by this specific one-step fermentation process. The key question was simple. Does daily feeding cause adverse effects? At the dose tested, the answer was no.

The NOAEL came out at 8000 mg/kg body weight per day. That is a strong safety marker for a food ingredient. The study also used genetic methods to engineer E. coli AS10 for direct production. The process itself is part of the safety story. The paper focuses on toxicology, not cost or yield. You should not assume process economics from the abstract alone.

Key findings

The central result is the NOAEL value. At 8000 mg/kg/day, rats tolerated the one-step allulose without observed harm. The study also confirms something formulators care about: D-allulose behaves like sucrose in key functional areas.

Property	D-allulose (one-step process)	Sucrose
Solubility	Similar	Reference
Texture	Similar	Reference
Thermal stability	Similar	Reference

These properties make the ingredient useful as a sugar substitute. You can start formulation with the expectation that it will handle moisture, mouthfeel, and heat like sugar does. That means less troubleshooting on your end.

What this means for manufacturers

This study gives you a direct answer when internal quality or regulatory teams ask about safety data. You are not relying on a generic allulose claim. You have a specific 90-day NOAEL for a specific production process. That matters when you audit suppliers. Ask them whether their allulose comes from a similar one-step fermentation or a different route. Then match the safety data to the production process.

For ingredient buyers, the functional data is just as useful. Solubility, texture, and thermal stability comparable to sucrose mean fewer surprises in pilot batches. You can formulate for sugar-like behavior and then adjust for the known differences in sweetness and glycemic response. The study does not claim that allulose is nutritionally identical to sugar. It does give you a safety foundation.

FAQ

What does NOAEL mean?

NOAEL stands for no-observed-adverse-effect level. In this study, it is 8000 mg/kg body weight per day in rats. That is the dose where no adverse effects appeared during the 90-day exposure.

Does this study apply to every allulose product?

No. It applies to D-allulose produced by the novel one-step fermentation process with the engineered E. coli AS10 strain. If your supplier uses a different process, you need matching safety data or a clear argument that the final ingredient is equivalent.

Can I use this paper in my own regulatory review?

You can cite it as part of a broader safety assessment. A single 90-day rat study does not replace a full dossier. You still need to check local regulations, intended use levels, and any additional requirements from your customers.

Where this leaves you

You have a specific toxicology result and a functional comparison to sucrose in one paper. The NOAEL of 8000 mg/kg/day gives you a defensible data point. The property similarities give you a starting point for formulation. That is enough to move forward in discussions with suppliers and internal technical teams. Use the study to ask sharper questions about the allulose on your ingredient list. Then let the data guide your next batch.